Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 S461-p
AMPKA1 S461-p
BLK Y194-p
CDK6 T463-p , S467-p
Hck Y194-p
IKKB S269-p
MAPKAPK2 S461-p
Pim2 S478-p
Src Y194-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S461-p
AMPKA1 S461-p
AMPKA1 S461-p
IKKB S269-p
MAPKAPK2 S461-p
Pim2 S478-p
PKACA S461-p
PKCA S461-p
Src Y194-p
Regulatory protein:
CD38 S461-p , S467-p
EGFR Y194-p
GCN5 S461-p
PCAF S461-p
Treatment:
3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one S461-p
Akt_inhibitor_VIII S461-p
angiotensin_2 S461-p , T463-p , S467-p
anisomycin S461-p , S478-p
antagomir S461-p
cisplatin S461-p , K472-ac
dasatinib S461-p
EGF Y194-p
etoposide K472-ac
glucose_starvation K472-ac
GSK2334470 S461-p
H2O2 Y194-p
hypertonic_buffer S461-p
hypoxia S461-p
ischemia S22-p
KU-55933 K472-ac
LY294002 S461-p
NAC Y194-p
nicotinamide K472-ac
oligomycin S461-p
PD98059 S461-p
PF3644022 S461-p
PFK-015 S461-p
PFK158 S461-p
PP2 Y194-p
saracatinib Y194-p
SB203580 S461-p
selisistat K472-ac
selumetinib S461-p
serum S461-p
SII_angiotensin_2 S461-p , T463-p , S467-p
siRNA S461-p , K472-ac , S478-p
torin_2 S461-p
trichostatin_A K472-ac
UV K472-ac
vanadate Y194-p
vemurafenib S461-p